Frances R. Balkwill

66.4k total citations · 15 hit papers
294 papers, 46.9k citations indexed

About

Frances R. Balkwill is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Frances R. Balkwill has authored 294 papers receiving a total of 46.9k indexed citations (citations by other indexed papers that have themselves been cited), including 136 papers in Oncology, 133 papers in Immunology and 74 papers in Molecular Biology. Recurrent topics in Frances R. Balkwill's work include Cytokine Signaling Pathways and Interactions (56 papers), Immunotherapy and Immune Responses (54 papers) and Chemokine receptors and signaling (37 papers). Frances R. Balkwill is often cited by papers focused on Cytokine Signaling Pathways and Interactions (56 papers), Immunotherapy and Immune Responses (54 papers) and Chemokine receptors and signaling (37 papers). Frances R. Balkwill collaborates with scholars based in United Kingdom, United States and Germany. Frances R. Balkwill's co-authors include Alberto Mantovani, Paola Allavena, Antonio Sica, Kellie A. Charles, Thorsten Hagemann, Frances Burke, Melania Capasso, Julia L. Wilson, Shanthini Mary Crusz and Hagen Kulbe and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Frances R. Balkwill

288 papers receiving 46.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cancer-related inflammation

2008 9.0k citations Frances R. Balkwill et al. profile →
Inflammation and cancer: back to Virchow?

2001 6.2k citations Frances R. Balkwill et al. profile →
Cancer and the chemokine network

2004 1.9k citations Frances R. Balkwill profile →
Tumour necrosis factor and cancer

2009 1.5k citations Frances R. Balkwill profile →
The tumor microenvironment at a glance

2012 1.4k citations Frances R. Balkwill, Melania Capasso et al. profile →
Smoldering and polarized inflammation in the initiation and promotion of malignant disease

2005 1.4k citations Frances R. Balkwill, Kellie A. Charles et al. profile →
Guidelines for the welfare and use of animals in cancer research

2010 1.1k citations Frances R. Balkwill et al. profile →
Inflammation and cancer: advances and new agents

2015 932 citations Frances R. Balkwill et al. profile →
TNF-α in promotion and progression of cancer

2006 747 citations Frances R. Balkwill profile →
Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis

1999 700 citations Frances Burke, Frances R. Balkwill et al. profile →
“Re-educating” tumor-associated macrophages by targeting NF-κB

2008 654 citations Thorsten Hagemann, Iain A. McNeish et al. profile →
Harnessing cytokines and chemokines for cancer therapy

2022 651 citations Frances R. Balkwill et al. profile →
The cytokine network

1989 637 citations Frances R. Balkwill, Frances Burke profile →
The significance of cancer cell expression of the chemokine receptor CXCR4

2004 628 citations Frances R. Balkwill profile →
Cancer-related inflammation: Common themes and therapeutic opportunities

2011 537 citations Frances R. Balkwill et al. profile →

Peers

Countries citing papers authored by Frances R. Balkwill

Since Specialization

Citations

This map shows the geographic impact of Frances R. Balkwill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frances R. Balkwill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frances R. Balkwill more than expected).

Fields of papers citing papers by Frances R. Balkwill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frances R. Balkwill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frances R. Balkwill. The network helps show where Frances R. Balkwill may publish in the future.

Co-authorship network of co-authors of Frances R. Balkwill

This figure shows the co-authorship network connecting the top 25 collaborators of Frances R. Balkwill. A scholar is included among the top collaborators of Frances R. Balkwill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frances R. Balkwill. Frances R. Balkwill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Biomimetic organo-hydrogels reveal the adipose tissue local mechanical anisotropy regulates ovarian cancer invasion 2025 ·Nature Communications ·Jordi Gonzalez‐Molina, (unknown), (unknown), (unknown), Okan Gultekin, Mohammed Fatih Rasul, (unknown), (unknown), (unknown), Twana Alkasalias, Sahar Salehi, Frances R. Balkwill, Kaisa Lehti, Julien E. Gautrot	0
2	Navitoclax, a Bcl-2/xL Inhibitor, and YM155, a Survivin Inhibitor, in Combination with Carboplatin, Effectively Inhibit Ovarian Cancer Tumor Growth 2025 ·Molecular Cancer Therapeutics ·Hilary A. Kenny, Carman Ka Man Ip, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Frances R. Balkwill, Chiara Battistini, Ugo Cavallaro, (unknown), Ernst Lengyel	0
3	Human 3D Ovarian Cancer Models Reveal Malignant Cell–Intrinsic and –Extrinsic Factors That Influence CAR T-cell Activity 2024 ·Cancer Research ·(unknown), (unknown), Florian Laforêts, Panoraia Kotantaki, Eleni Maniati, Ranjit Manchanda, Alessandro Annibaldi, (unknown), (unknown), Julien E. Gautrot, Frances R. Balkwill	9
4	The Tumor Microenvironment of Clear-Cell Ovarian Cancer 2022 ·Cancer Immunology Research ·(unknown), Rowan Miller, Florian Laforêts, Panoraia Kotantaki, Dale W. Garsed, Rebecca Kristeleit, David D.L. Bowtell, Jacqueline McDermott, Eleni Maniati, Frances R. Balkwill	21
5	Immune Mechanisms of Resistance to Cediranib in Ovarian Cancer 2022 ·Molecular Cancer Therapeutics ·Ganga Gopinathan, Chiara Berlato, Anissa Lakhani, Ludmila Szabova, (unknown), Ana‐Rita Pedrosa, Florian Laforêts, Eleni Maniati, Frances R. Balkwill	7
6	Chemotherapy Induces Tumor-Associated Macrophages that Aid Adaptive Immune Responses in Ovarian Cancer 2021 ·Cancer Immunology Research ·(unknown), Chiara Berlato, Eleni Maniati, Anissa Lakhani, (unknown), Panoraia Kotantaki, (unknown), Steffen Böhm, Simon T. Barry, Alessandro Annibaldi, Desmond P.J. Barton, Frances R. Balkwill	38
7	Reduced Expression of Histone Methyltransferases KMT2C and KMT2D Correlates with Improved Outcome in Pancreatic Ductal Adenocarcinoma 2016 ·Cancer Research ·(unknown), Jun Wang, Eleni Maniati, James A. Heward, (unknown), Hemant M. Kocher, Sarah A. Martin, Claude Chelala, Frances R. Balkwill, Jude Fitzgibbon, Richard Grose	72
8	CRISPR/Cas9-Mediated Trp53 and Brca2 Knockout to Generate Improved Murine Models of Ovarian High-Grade Serous Carcinoma 2016 ·Cancer Research ·Josephine Walton, Julianna Blagih, Darren Ennis, Elaine Leung, Suzanne Dowson, Malcolm Farquharson, Laura A. Tookman, Clare Orange, Dimitris Athineos, Susan Mason, David Stevenson, Karen Blyth, Douglas Strathdee, Frances R. Balkwill, Karen H. Vousden, Michelle Lockley, Iain A. McNeish	150
9	A Strong B-cell Response Is Part of the Immune Landscape in Human High-Grade Serous Ovarian Metastases 2016 ·Clinical Cancer Research ·Anne Montfort, Oliver M.T. Pearce, Eleni Maniati, Benjamin G. Vincent, Lisa M. Bixby, Steffen Böhm, Thomas Dowe, Edmund H. Wilkes, Probir Chakravarty, R. Thompson, Joanne Topping, Pedro R. Cutillas, Michelle Lockley, Jonathan S. Serody, Melania Capasso, Frances R. Balkwill	172
10	Neoadjuvant Chemotherapy Modulates the Immune Microenvironment in Metastases of Tubo-Ovarian High-Grade Serous Carcinoma 2016 ·Clinical Cancer Research ·Steffen Böhm, Anne Montfort, Oliver M.T. Pearce, Joanne Topping, Probir Chakravarty, (unknown), Andrew Clear, (unknown), Darren Ennis, Thomas Dowe, Amanda Fitzpatrick, Elly Brockbank, Alexandra Lawrence, Arjun Jeyarajah, Asma Faruqi, Iain A. McNeish, Naveena Singh, Michelle Lockley, Frances R. Balkwill	111
11	Interleukin-6 Stimulates Defective Angiogenesis 2015 ·Cancer Research ·Ganga Gopinathan, Carla Milagre, Oliver M.T. Pearce, Louise E. Reynolds, Kairbaan Hodivala‐Dilke, David A. Leinster, Haihong Zhong, Robert E. Hollingsworth, R. Thompson, James R. Whiteford, Frances R. Balkwill	191
12	Adaptive Upregulation of EGFR Limits Attenuation of Tumor Growth by Neutralizing IL6 Antibodies, with Implications for Combined Therapy in Ovarian Cancer 2015 ·Cancer Research ·Carla Milagre, Ganga Gopinathan, (unknown), Richard G. Thompson, Hagen Kulbe, Haihong Zhong, Robert E. Hollingsworth, Richard Grose, David D.L. Bowtell, Daniel Hochhauser, Frances R. Balkwill	36
13	Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer 2011 ·Clinical Cancer Research ·Jermaine Coward, Hagen Kulbe, Probir Chakravarty, David P. Leader, Vessela Vassileva, David A. Leinster, R. Thompson, Tiziana Schioppa, (unknown), Jessica Vermeulen, Naveena Singh, Norbert Avril, Jeff Cummings, Elton Rexhepaj, Karin Jirström, William M. Gallagher, Donal J. Brennan, Iain A. McNeish, Frances R. Balkwill	313
14	A Dynamic Inflammatory Cytokine Network in the Human Ovarian Cancer Microenvironment 2011 ·Cancer Research ·Hagen Kulbe, Probir Chakravarty, David A. Leinster, Kellie A. Charles, Joseph Kwong, Richard G. Thompson, Jermaine Coward, Tiziana Schioppa, Stephen C. Robinson, William M. Gallagher, Laura Galletta, Michael A. Salako, John F. Smyth, Thorsten Hagemann, Donal J. Brennan, David D.L. Bowtell, Frances R. Balkwill	171
15	An antagonist of the chemokine receptor CXCR4 induces mitotic catastrophe in ovarian cancer cells 2009 ·Molecular Cancer Therapeutics ·Joseph Kwong, Hagen Kulbe, Donald Wong, Probir Chakravarty, Frances R. Balkwill	62
16	A vicious circle of TNF-α, CXCL12 and CXCR4 influences growth and spread of human epithelial ovarian cancer 2006 ·Cancer Research ·Hagen Kulbe, Julia L. Wilson, R. Thompson, Thorsten Hagemann, (unknown), (unknown), A. Ayhan, Frances R. Balkwill	2
17	IFN-gamma induces apoptosis in ovarian cancer cells in vivo and in vitro. 2003 ·PubMed ·Lucy Wall, Frances Burke, Caroline Barton, John Smyth, Frances R. Balkwill	85
18	Monoclonal antibodies that distinguish between subspecies of human interferon-alpha and that detect interferon oligomers. 1984 ·The Journal of Immunology ·M Shearer, Joyce Taylor‐Papadimitriou, (unknown), Frances R. Balkwill	17
19	An Animal Model System for Investigating the AntiTumor Effects of Human Interferon 1983 ·Journal of Interferon Research ·Frances R. Balkwill, (unknown), Victoria H. Freedman, E. Birgitte Lane, K. H. Fantes	12
20	Effects of HuIFN-α2 and HuIFN-α (Namalwa) on Breast Cancer Cells Grown in Culture and as Xenografts in the Nude Mouse 1982 ·Journal of Interferon Research ·Joyce Taylor‐Papadimitriou, M Shearer, Frances R. Balkwill, K. H. Fantes	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact